Reason for request
Inclusion
Clinical Benefit
| Substantial |
Substantial actual benefit |
Clinical Added Value
| no clinical added value |
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection. |
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
QVbyZ1qK7ArFUukZ
